Health Care Select Sector SPDR Fund (XLV)
| Assets | $37.46B |
| Expense Ratio | 0.09% |
| PE Ratio | 32.10 |
| Shares Out | 265.82M |
| Dividend (ttm) | $2.30 |
| Dividend Yield | 1.64% |
| Ex-Dividend Date | Dec 23, 2024 |
| Payout Ratio | 52.55% |
| 1-Year Return | +0.36% |
| Volume | 7,659,928 |
| Open | 140.94 |
| Previous Close | 141.13 |
| Day's Range | 140.18 - 141.40 |
| 52-Week Low | 135.95 |
| 52-Week High | 159.64 |
| Beta | 0.68 |
| Holdings | 63 |
| Inception Date | Dec 16, 1998 |
About XLV
Fund Home PageThe Health Care Select Sector SPDR Fund (XLV) is an exchange-traded fund that is based on the Health Care Select Sector index. The fund tracks health care stocks from within the S&P 500 Index, weighted by market cap. XLV was launched on Dec 16, 1998 and is issued by State Street.
Top 10 Holdings
56.40% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 11.57% |
| UnitedHealth Group Incorporated | UNH | 9.11% |
| Johnson & Johnson | JNJ | 6.89% |
| AbbVie Inc. | ABBV | 5.95% |
| Merck & Co., Inc. | MRK | 4.94% |
| Thermo Fisher Scientific Inc. | TMO | 4.16% |
| Intuitive Surgical, Inc. | ISRG | 4.03% |
| Abbott Laboratories | ABT | 3.83% |
| Danaher Corporation | DHR | 3.01% |
| Pfizer Inc. | PFE | 2.91% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 23, 2024 | $0.622 | n/a |
| Sep 23, 2024 | $0.577 | Sep 25, 2024 |
| Jun 24, 2024 | $0.573 | Jun 26, 2024 |
| Mar 18, 2024 | $0.523 | Mar 21, 2024 |
| Dec 18, 2023 | $0.598 | Dec 21, 2023 |
| Sep 18, 2023 | $0.540 | Sep 21, 2023 |
News
Final Trades: QXO, Stanley Black & Decker, Healthcare and Applovin
The Investment Committee reveals their top stocks to watch. Don't miss their picks!
Healthcare sector poised for rebound in 2025
The JPMorgan Healthcare Conference is a place where deals happen. As the conference kicked off, deals were announced from Eli Lilly (LLY), Johnson & Johnson (JNJ), and GSK (GSK).
GLP-1 makers could be under pressure in 2025
Jared Holz, Mizuho, joins 'Fast Money' to talk what is next for the obesity drug makers in 2025.
Healthcare has 'been so bad, maybe it's gonna be good' in 2025, says Mizuho's Jared Holz
Jared Holz, Mizuho Securities America healthcare sector strategist, joins CNBC's 'Squawk on the Street' to discuss outlooks on the healthcare sector in the new year
Healthcare Stocks: 2025 Outlook
I forecast healthcare stocks, especially biopharmaceuticals, to outperform the general averages due to four key investment themes. US healthcare expenditures are expected to grow at an annualized rate...
We're bullish on tech and healthcare going into 2025, says Citizens JPM's Mark Lehmann
Mark Lehmann, head of Citizens JPM, joins CNBC's 'Money Movers' to discuss what sectors he's keeping an eye on going into 2025.
Final Trade: XLV, DEO, OIH & BTC
The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
The M&A 'animal spirits' would be a tailwind for the healthcare sector, says JPMorgan's Meera Pandit
Meera Pandit, JPMorgan Asset Management global market strategist, joins 'Closing Bell' to discuss the road ahead for markets and which sectors will be the winners and losers in 2025.
Tema ETFs CIO says health care innovation to continue next year
Yuri Khodjamirian, CIO at Tema ETFs, discusses the outlook for the health care sector in 2025.
Final Trade: PYPL, XLV, GOOGL, X
The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
Final Trade: IWM, XLV
The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
Why investors should avoid healthcare stocks
Howard Capital Management CEO and CIO Vance Howard joins Wealth! to discuss his outlook on current market (^DJI, ^IXIC, ^GSPC) dynamics and his top recommendations.
Investing in healthcare innovation will be a powerful driver of returns: Principal Asset's Maris
George Maris, Principal Asset Management CIO, joins 'Money Movers' to discuss why Maris likes certain parts of the healthcare space, if the overall market feels euphoric, and much more.
We're trimming healthcare to be more defensive, says BMO's Brian Belski
Brian Belski, Chief Investment Strategist at BMO Capital Markets, joins 'Halftime Report' to detail his latest portfolio moves.
XLV: Healthcare Stocks In Critical Condition (Rating Downgrade)
The healthcare sector, including the SPDRs Select Health Care ETF, faces high uncertainty due to political factors and elevated valuations, prompting a downgrade from hold to sell. My investment appro...
RFK Jr.'s HHS nomination sparks concern over pharma stocks
President-elect Trump's decision to nominate Robert F. Kennedy Jr. as the Secretary of Health and Human Services (HHS) has sparked concerns, particularly about his skepticism toward the pharmaceutical...
Jim Cramer on why RFK Jr. could upend HHS
Mad Money' host Jim Cramer explains why vaccine skeptic Robert F. Kennedy Jr. could upend the Department of Health and Human Services if he leads it.
5 Healthcare Stocks to Buy in a Beaten-Up Sector
It has been a shaky time for healthcare stocks, but that only presents a buying opportunity.
Regulatory outlook is hazy for health care under Trump admin, says former Thomson Reuters CEO
Thomas Glocer, former Thomson Reuters CEO, joins 'Squawk on the Street' to discuss how policy is expected in the health care sector, how discussions are going regarding M&A, and much more.
Why most healthcare stocks are falling with Trump's win, with some exceptions
Investors are worried about what a Trump administration means for hospital operators and vaccine makers, but are optimistic about the fate of Medicare Advantage plan providers.
Trump Will Create New Winners and Losers in Healthcare
Market reactions sharply diverged among healthcare companies as investors expect changes to Obamacare, Medicare.
XLV: Here Is A Good Risk-Return Ratio
The healthcare sector shows resilience and strong earnings growth prospects for Q3 and Q4. The entire US market is expensive, driven by peak company margins. Healthcare sector showed strong returns du...
'Overuse' is causing healthcare insurer headwinds, says Mizuho's Jared Holz
Jared Holz, Mizuho healthcare equity strategist, joins CNBC's 'The Exchange' to discuss why healthcare insurer stocks are down, whether weight loss drugs have any impact, and more.
XLV ETF: Time To Start A DCA In Healthcare Sector
I have decided to continue my Dollar Cost Averaging, or DCA, strategy in the healthcare sector through The Health Care Select Sector SPDR® Fund ETF. The XLV ETF offers a low expense ratio of 0.09%, a ...